PCC probiomics limited

flu vax trial, page-9

  1. 1,177 Posts.
    From previous post:

    "4. You may be aware that a Swedish company, Biogaia, has taken an option to purchase 18m shares in the company at $0.08 per share. Details were contained in the 2006 annual report. They have requested an independent study of our probiotic strain and this has now been completed by scientists at the CSIRO. The report will go to Biogaia this week."
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.